November 17, 2026 · Aesthetic plastic surgery · DOI: 10.1007/s00266-026-06437-3

Subconjunctival Injection of Hyaluronic Acid Versus Triamcinolone Acetonide in Thyroid Eye Disease-related Upper Eyelid Retraction: A Pilot Study.

Listen to this summary

This pilot study asked whether a single subconjunctival injection of hyaluronic acid (Restylane Eyelight) or triamcinolone acetonide can objectively improve upper eyelid retraction in patients with thyroid eye disease, measured by MRD1 on standardized photographs over six months. In 16 eyes from 13 patients (11 receiving triamcinolone, 5 receiving hyaluronic acid), both treatments produced a significant reduction in MRD1 of about 1.0 mm at six months, with no significant difference between agents and high, comparable satisfaction. Only mild transient edema and small depot formation were observed, suggesting both may be safe, minimally invasive options for mild-to-moderate cases, though the small, unbalanced sample limits firm conclusions.

Fabio Daniel Padilla-Pantoja, Hortensia Sanchez-Tocino, Irene Bermúdez-Castellanos, Victoria Eugenia Marqués-Fernández, Alicia Galindo-Ferreiro

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play